Fortress Biotech, Inc. financial data

Symbol
FBIO, FBIOP on Nasdaq
Location
1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 174 % +30.8%
Quick Ratio 20.1 % +51.5%
Debt-to-equity 366 % -51.2%
Return On Equity 12 % -98.2%
Return On Assets 2.4 %
Operating Margin -191 % -13.6%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 31M shares +12.4%
Entity Public Float 30.8M USD -41.8%
Common Stock, Value, Issued 31K USD +10.7%
Weighted Average Number of Shares Outstanding, Basic 27.2M shares +38.3%
Weighted Average Number of Shares Outstanding, Diluted 33.1M shares +68%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 17.6M USD +20.5%
Research and Development Expense 61M USD -52%
Costs and Expenses 152M USD -9.92%
Operating Income (Loss) -89.5M USD +15.6%
Nonoperating Income (Expense) 36M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 8.85M USD
Income Tax Expense (Benefit) 269K USD -40.1%
Net Income (Loss) Attributable to Parent 3.99M USD
Earnings Per Share, Basic 0 USD/shares +99.7%
Earnings Per Share, Diluted 0 USD/shares +98.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 86.2M USD +46.5%
Accounts Receivable, after Allowance for Credit Loss, Current 18M USD +68.5%
Inventory, Net 11.8M USD +0.25%
Assets, Current 119M USD +37.4%
Property, Plant and Equipment, Net 2.61M USD -23.3%
Operating Lease, Right-of-Use Asset 12.3M USD -12.9%
Other Assets, Noncurrent 18.1M USD +441%
Assets 181M USD +42.7%
Accounts Payable, Current 18.8M USD -44.8%
Accrued Liabilities, Current 45.2M USD -30%
Liabilities, Current 54.1M USD -23.1%
Deferred Income Tax Liabilities, Net 233K USD
Operating Lease, Liability, Noncurrent 12.8M USD -16.5%
Other Liabilities, Noncurrent 1.62M USD -7.82%
Liabilities 116M USD -16.9%
Retained Earnings (Accumulated Deficit) -730M USD +0.54%
Stockholders' Equity Attributable to Parent 55.9M USD +164%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 65.2M USD
Liabilities and Equity 181M USD +42.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.6M USD +22.9%
Net Cash Provided by (Used in) Financing Activities 52.1M USD +87.2%
Net Cash Provided by (Used in) Investing Activities 1.17M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 31M shares +12.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 33.7M USD +1265%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 87.4M USD +43.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.32M USD +100%
Deferred Tax Assets, Valuation Allowance 378M USD +3.16%
Deferred Tax Assets, Gross 385M USD +2.87%
Operating Lease, Liability 14.9M USD -16.4%
Depreciation 489K USD -54%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 17.9M USD -17.8%
Property, Plant and Equipment, Gross 7.66M USD -50.1%
Operating Lease, Liability, Current 2.13M USD -15.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.94M USD -10.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.94M USD -17.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.98M USD -24.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.97M USD +1.51%
Deferred Tax Assets, Operating Loss Carryforwards 233M USD +10.1%
Preferred Stock, Shares Issued 3.43M shares 0%
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 3.2M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.01M USD +1.52%
Operating Lease, Payments 852K USD -7.39%
Additional Paid in Capital 786M USD +4.07%
Preferred Stock, Shares Outstanding 3.43M shares 0%
Amortization of Intangible Assets 4.18M USD +30.7%
Deferred Tax Assets, Net of Valuation Allowance 6.66M USD -11.4%
Share-based Payment Arrangement, Expense 42.5M USD +111%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%